Takuma Hayashi is a professor at Section Head,
National Hospital Organization Kyoto Medical Center, Japan. He received his
Ph.D. and MBBS. from the University of Tokyo in 1994. He was in research
training as a resident staff member at the National Cancer Center, Tokyo,
Japan, for 3 years until 1994, and joined WI/M.I.T. that year. He completed
postdoctoral training in the laboratory of Dr. Rick A. Young (WI/M.I.T.). After
postdoctoral training, he achieved a lecturer position at Harvard Medical
School in 1997. He has been studying the antigen presentation system by MHC
class I with LMP2-deficient mice under the cooperation of Dr. Susumu Tonegawa
(Nobel Laureate, M.I.T.). He identifies diagnostic biomarkers, LMP2, Cyclin B1,
and Cyclin E, for malignant tumors, i.e., uterine leiomyosarcoma and BRCA1 and
S100A4 for ovarian carcinoma. His current research focus is on a molecular
approach to tumorigenesis of uterine leiomyosarcoma and ovarian cancer.
Biography: Dr. IKuo Konishi is the director of the national hospital organization
Kyoto Medical Center and is also an emeritus professor at the Faculty of
Medicine, Kyoto University. Dr. Ikuo Konishi is a specialist in obstetrics and
gynecology and a former director of the Japanese Society of Obstetrics and
Gynecology, and Dr. Konishi is also the director of Asian Gynecology
Association. Dr. Ikuo Konishi is on the Advisory Committee of the World Obstetrics
and Gynecology Association (FIGO) Oncology Committee. Dr. Ikuo Konishi, also is International
Member of the Female Genital Tumors classification on the World Health Organization
(WHO).
